Beijing ConST Instruments Technology Inc (300445) Fair Value & Analysis
Technology · CN · Market cap 4.9B CNY
Analysis
Beijing ConST Instruments Technology Inc (300445) currently trades at ¥21.91, while our model-based Fair Value estimate is ¥9.83 — implying the stock looks roughly 55.1% overvalued today. We read business quality at 94/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Beijing ConST Instruments Technology Inc., together with its subsidiaries, researches, develops, manufactures, and sells digital testing instruments and equipment in China. The company offers pressure detection products, including pressure calibrators, intelligent pressure controllers, digital pressure gauges, high-precision pressure guage, pressure pumps, intelligent identification devices, high-precision electrical measurement products, and pressure accessories; and process signal products, such as process and loop calibrators, and process signal accessories. It also provides temperature detection products intelligent dry block oven, thermometers, intelligent constant temperature baths, thermocouple calibration furnaces, temperature accessories, and temperature and humidity verification products; professional software; and professional solutions for pressure, process, temperature, temperature, and humidity detection. In addition, the company involved in technical testing services;…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.